Efficacy of a prophylactic human papillomavirus vaccine against high-grade vulval and vaginal intraepithelial neoplasia

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.3, 2008-05, pp. : 325-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prophylactic human papillomavirus vaccine

By Paavonen Jorma Lehtinen Matti

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 5-6

Future Medicine

Access to resources Recommend Favorite

Trends in the occurrence of high‐grade anal intraepithelial neoplasia in San Francisco: 2000‐2009

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3539-3545

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trends in cervical intraepithelial neoplasia Grade 2+ after human papillomavirus vaccination: The devil is in the details

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2674-2677

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population‐based trends in high‐grade cervical lesions in the early human papillomavirus vaccine era in the United States

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2775-2781

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term risk of cervical intraepithelial neoplasia grade 3 or worse according to high‐risk human papillomavirus genotype and semi‐quantitative viral load among 33,288 women with normal cervical cytology

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 1, 2015-07 ,pp. : 193-203

John Wiley & Sons Inc

Access to resources Recommend Favorite